• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Mindwalk Advances Universal Influenza Program With Breakthrough

    PHARMIWEB

    Mindwalk Reports Record Growth, Advances AI Asset Pipeline

    BUSINESSWIRE

    ImmunoPrecise Transforms into MindWalk, Emphasizing AI Future

    FIERCE PHARMA

    ImmunoPrecise Advances Universal Dengue Vaccine to Preclinical

    BUSINESSWIRE

    ImmunoPrecise Sells Facilities to AVS Bio for AI Innovation

    BUSINESSWIRE

    ImmunoPrecise Adds Data Expert Jeff Fried to Advisory Board

    BUSINESSWIRE

    Industry Veteran Jon Lieber Joins ImmunoPrecise Antibodies Board

    BUSINESSWIRE

    ImmunoPrecise Advances Dengue Vaccine With LENSai Platform

    BUSINESSWIRE

    ImmunoPrecise Announces AI Breakthrough in Dengue Vaccine

    BUSINESSWIRE

    ImmunoPrecise Antibodies Engages CORE IR for Investor Engagement

    BUSINESSWIRE

    ImmunoPrecise Antibodies to Present at Maxim Group`s 2025 Virtual

    BUSINESSWIRE

    IPA’s LENSai™ Delivers Fast, Gold-Standard Mapping

    BUSINESSWIRE

    ImmunoPrecise Antibodies Aligns LENSai with FDA`s Non-Animal Test

    BUSINESSWIRE

    ImmunoPrecise Antibodies Reports Q3 Fiscal Year 2025 Results

    BUSINESSWIRE

    ImmunoPrecise Antibodies partners with biotech leader for cancer

    BUSINESSWIRE

    ImmunoPrecise & RIBOPRO Partner for AI-Powered Antibody Discovery

    CONTRACTPHARMA

    ImmunoPrecise Moves To Nasdaq Capital, Gets Bid Price Extension

    BUSINESSWIRE

    ImmunoPrecise Antibodies Shows Confidence with Share Purchases

    BUSINESSWIRE

    ImmunoPrecise Reports Q2 FY2025 Results And Highlights

    BUSINESSWIRE

    ImmunoPrecise to Host Techday on AI & Biologics Innovation

    BUSINESSWIRE

    ImmunoPrecise Celebrates Nobel Prize Advances AI Protein Design

    BUSINESSWIRE

    ImmunoPrecise Advances Rabbit Antibody Developments

    BUSINESSWIRE

    ImmunoPrecise Reports Q1 FY2025 Results

    BUSINESSWIRE

    ImmunoPrecise Antibodies Announces CFO Transition

    BUSINESSWIRE

    ImmunoPrecise Antibodies Invites Investors to Interview with Market Radius

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.